Chancery Says Takeda Liable For AbbVie's Lupron Supply Lag
Japanese drugmaker Takeda Pharmaceutical Co. Ltd. is liable to distributor AbbVie Endocrine Inc. for breaching their supply agreement for cancer drug Lupron Depot, a Delaware Chancery judge ruled Wednesday, teeing the companies up for...To view the full article, register now.
Already a subscriber? Click here to view full article